Next Article in Journal
Targeting Mcl-1 Degradation by Bergenin Inhibits Tumorigenesis of Colorectal Cancer Cells
Next Article in Special Issue
Mucosal Genes Expression in Inflammatory Bowel Disease Patients: New Insights
Previous Article in Journal
Synthetic Methodologies and Therapeutic Potential of Indole-3-Carbinol (I3C) and Its Derivatives
Previous Article in Special Issue
Pioglitazone Has a Null Association with Inflammatory Bowel Disease in Patients with Type 2 Diabetes Mellitus
 
 

Order Article Reprints

Journal: Pharmaceuticals, 2023
Volume: 16
Number: 239

Article: Real-World Study on Vedolizumab Serum Concentration, Efficacy, and Safety after the Transition from Intravenous to Subcutaneous Vedolizumab in Inflammatory Bowel Disease Patients: Single-Center Experience
Authors: by Vlasta Oršić Frič, Vladimir Borzan, Ines Šahinović, Andrej Borzan and Sven Kurbel
Link: https://www.mdpi.com/1424-8247/16/2/239

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop